arrow
J

John V. Pearson

QIMR Berghofer Medical Research Institute
H指数:77
被引数:5.6万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Enhanced measures of neoantigenicity capture unique tumor-immune interactions across primary melanoma subtypes

增强型新抗原性指标捕捉不同原发性黑色素瘤亚型中的独特肿瘤-免疫相互作用

2026-05-260
OAAI
Multi-omics reveals key molecular and cellular features of advanced small cell lung cancers associated with distinct therapeutic opportunities

多组学揭示了与不同治疗机会相关联的晚期小细胞肺癌的关键分子和细胞特征

2026-03-170
OAAI
Mapping the Proteomic Landscape of Pancreatic Cancer: Prognostic Insights and Subtype Stratification

绘制胰腺癌的蛋白质组学图谱:预后见解与亚型分层

2025-10-010
OA
Multiomic profiling of checkpoint inhibitor-treated melanoma: Identifying predictors of response and resistance, and markers of biological discordance (vol 40, pg 88, 2022)

多组学分析:检查点抑制剂治疗的黑色素瘤:识别应答和耐药的预测因子,以及生物学不一致性的标志物(卷40,页88,2022)

2025-02-010
PRE
Performance of somatic structural variant calling in lung cancer using Oxford Nanopore sequencing technology

使用牛津纳米孔测序技术在肺癌中体细胞结构变异调用的性能

2024-09-300
OAAI
Discrepancies in tumor mutation burden reporting from sequential endobronchial ultrasound transbronchial needle aspiration samples within single lymph node stations - brief report
2023-10-190
OAAI
The clinical utility and costs of whole-genome sequencing to detect cancer susceptibility variants-a multi-site prospective cohort study

全基因组测序检测癌症易感性变异的临床效用和成本 -- 一项多中心前瞻性队列研究

2023-09-194
OAAI
Performance of tumour microenvironment deconvolution methods in breast cancer using single-cell simulated bulk mixtures

使用单细胞模拟散装混合物在乳腺癌中肿瘤微环境去卷积方法的性能

2023-09-1613
OAAI
Multi-omic features of oesophageal adenocarcinoma in patients treated with preoperative neoadjuvant therapy
2023-05-319
OAAI
A proteomic-based prognostic signature of pancreatic adenocarcinoma
2023-04-040
PRE
Australian Genomics: Outcomes of a 5-year national program to accelerate the integration of genomics in healthcare

澳大利亚基因组学: 一项为期5年的国家计划的成果,以加速基因组学在医疗保健中的整合

2023-03-0130
OAAI
Heritable defects in telomere and mitotic function selectively predispose to sarcomas
Science
IF45.8
2023-01-010
OA